Search research articles
Contact Us
Filters
Showing results (51-60 of 116) with videos related to
Page
of 12
Sort By:
Kidney360
|
August 26, 2025
Managing Dysregulated Vitamin D Metabolism in CKD: Time to Update Conventional Wisdom?
Charles W Bishop, Akhtar Ashfaq, John Choe, et al.
American Journal of Nephrology
|
November 9, 2007
Abnormal bone and mineral metabolism in kidney transplant patients--a review
Stuart M Sprague, Vasily Belozeroff, Mark D Danese, et al.
Kidney International Reports
|
May 14, 2023
Quantitative Blood Oxygenation Level Dependent Magnetic Resonance Imaging for Estimating Intra-renal Oxygen Availability Demonstrates Kidneys Are Hypoxemic in Human CKD
Pottumarthi V Prasad, Lu-Ping Li, Bradley Hack, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
December 6, 2008
Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial
Stuart M Sprague, Hanna Abboud, Ping Qiu, et al.
American Journal of Nephrology
|
March 18, 2019
Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease
Stephen A Strugnell, Stuart M Sprague, Akhtar Ashfaq, et al.
Journal of Nephrology
|
February 9, 2022
Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence
Daniel W Coyne, Stuart M Sprague, Marc Vervloet, et al.
American Journal of Nephrology
|
December 13, 2023
Serum Phosphorus Management with Sucroferric Oxyhydroxide as a First-Line Phosphate Binder within the First Year of Hemodialysis
Juan A Medaura, Meijiao Zhou, Linda H Ficociello, et al.
Artificial Organs
|
November 12, 2013
A receptor-based bioadsorbent to target advanced glycation end products in chronic kidney disease
Yangrong Zhang, Karen A Lapidos, Anca Gal-Moscovici, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 27, 2008
Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: a multicenter study
Rajnish Mehrotra, Kevin J Martin, Steven Fishbane, et al.
Seminars in Dialysis
|
January 25, 2007
Which of the K/DOQI guidelines for bone disease in dialysis patients should be changed?
Anca Gal-Moscovici, Stuart M Sprague, Alastair J Hutchison, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 116) with videos related to
Sort By:
Page
of 12
Kidney360
|
August 26, 2025
Managing Dysregulated Vitamin D Metabolism in CKD: Time to Update Conventional Wisdom?
Charles W Bishop, Akhtar Ashfaq, John Choe, et al.
American Journal of Nephrology
|
November 9, 2007
Abnormal bone and mineral metabolism in kidney transplant patients--a review
Stuart M Sprague, Vasily Belozeroff, Mark D Danese, et al.
Kidney International Reports
|
May 14, 2023
Quantitative Blood Oxygenation Level Dependent Magnetic Resonance Imaging for Estimating Intra-renal Oxygen Availability Demonstrates Kidneys Are Hypoxemic in Human CKD
Pottumarthi V Prasad, Lu-Ping Li, Bradley Hack, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
December 6, 2008
Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial
Stuart M Sprague, Hanna Abboud, Ping Qiu, et al.
American Journal of Nephrology
|
March 18, 2019
Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease
Stephen A Strugnell, Stuart M Sprague, Akhtar Ashfaq, et al.
Journal of Nephrology
|
February 9, 2022
Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence
Daniel W Coyne, Stuart M Sprague, Marc Vervloet, et al.
American Journal of Nephrology
|
December 13, 2023
Serum Phosphorus Management with Sucroferric Oxyhydroxide as a First-Line Phosphate Binder within the First Year of Hemodialysis
Juan A Medaura, Meijiao Zhou, Linda H Ficociello, et al.
Artificial Organs
|
November 12, 2013
A receptor-based bioadsorbent to target advanced glycation end products in chronic kidney disease
Yangrong Zhang, Karen A Lapidos, Anca Gal-Moscovici, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 27, 2008
Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: a multicenter study
Rajnish Mehrotra, Kevin J Martin, Steven Fishbane, et al.
Seminars in Dialysis
|
January 25, 2007
Which of the K/DOQI guidelines for bone disease in dialysis patients should be changed?
Anca Gal-Moscovici, Stuart M Sprague, Alastair J Hutchison, et al.
Page
of 12